Skip to main content

Table 2 Comparative between COVID-19 and Non-COVID-19 Protocols (Apr 2020 – Dec 2021)

From: Primary health care research in COVID-19: analysis of the protocols reviewed by the ethics committee of IDIAPJGol, Catalonia

Total protocols 469

COVID-19

No COVID-19

p value

N (%)

208 (44.3)

261 (55.7)

0.016

Study design

 Interventional study

17 (8.2)

48 (18.4)

0.001

 Observational study

162 (77.9)

161 (61.7)

0.000

 Qualitative study

18 (8.7)

34 (13.0)

0.134

 Othersa

11 (5.3)

18 (6.9)

0.473

Funding

 External/Public grant

47 (22.6)

37 (14.2)

0.018

 Internal grant

7 (3.4)

12 (4.6)

0.501

 Private funding

33 (15.9)

64 (24.5)

0.021

 No funding

121 (58.2)

148 (56.7)

0.749

PI characteristics

 Gender (Female)

122 (58.7)

174 (66.7)

0.002

 Holds a PhD degree (yes)

86 (41.3)

88 (33.7)

0.019

 Research group membership (yes)

74 (35.6)

61 (23.4)

0.004

Professionals

 General Practitioners (GP)

100 (48.1)

91 (34.9)

0.004

 Physicians other than GP

34 (16.3)

33 (12.6)

0.255

 Pediatricians

7 (3.4)

6 (2.3)

0.485

 Physicians (Gynecologist)

0 (0.0)

6 (2.3)

0.008

 Nurse

29 (13.9)

66 (25.3)

0.002

 Other health professionals

10 (4.8)

14 (5.4)

0.786

 Pharmacists

6 (2.9)

10 (3.8)

0.575

 Biostatisticians/IT

2 (1.0)

3 (1.1)

0.844

 Others

4 (1.9)

10 (3.8)

0.228

 Unknown

16 (7.7)

22 (8.4)

0.771

EC Results

 Approval

175 (84.1)

209 (80.1

0.257

  Days until approval

   0

46 (26.3)

57 (27.3)

0.828

   1–30

16 (9.1)

54 (25.8)

0.009

   31–90

67 (38.3)

65 (31.1)

0.197

   91–180

44 (25.1)

28 (13.4)

0.192

   > 6 months

2 (1.1)

5 (2.4)

0.362

 Modification required

32 (15.4)

49 (18.8)

0.335

 Withdrawn

1 (0.5)

2 (0.8)

0.696

 Denied

0 (0.0)

1 (0.4)

0.279

Days to be approved (mean, SD)

33.3 (45.0)

40.1 (52.1)

0.101

  1. aOthers: Others: economist, sociologists, engineer, journalists, geography and history, trade and marketing